skip to main content

Risk of unexpected sarcoma being discovered after hysterectomy appears fairly rare

Uterine sarcoma was found in 0.22% of women following a hysterectomy for benign conditions, a new study finds. This may have implications for the risks associated with controversial power morcellation procedures.

Notch signaling pathway in breast cancer stem cells: A promising therapeutic target

A new study provides direct evidence for the role of the Notch pathway in breast cancer stem cell activity as demonstrated by a Notch reporter system. Notch signaling regulates embryonic and tissue-specific stem cells, which are altered in a number of cancers, including breast cancer.

Dr. Theodore Lawrence named director of University of Michigan Rogel Cancer Center

Theodore S. Lawrence, M.D., Ph.D., has been named the director of the University of Michigan Rogel Cancer Center. Lawrence, who is also chair of radiation oncology, succeeds founding director Max S. Wicha, M.D.

Sarcoma Information and Resources

American Cancer Society Cancer Action Network Inc.
www.acscan.org

Amschwand Sarcoma Cancer Foundation
www.sarcomacancer.org/index.php?page=research

Critical Mass
www.criticalmass.org

Cure Our Children
www.cureourchildren.org

CureSearch for Children’s Cancer
www.curesearch.org

Sarcoma Survivorship Team

 

This program is not seeing patients at this time. Please call our Cancer AnswerLine™ at 800-865-1125 for information on who can help you with your survivorship questions.

Lung screening guidelines improve on study findings

A set of guidelines developed to help standardized lung cancer screening would have generated considerably fewer false-positives than the National Lung Screening Trial produced, according to a new retrospective study.

Medicare approves lung cancer screening coverage

The Centers for Medicare and Medicaid Services have finalized coverage guidelines for lung cancer screening with CT scans for people at high-risk of developing lung cancer. Coverage goes into effect immediately.

MDS Treatment Options

Treatment options for patients with myelodysplastic syndromes range from supportive care that helps relieve symptoms to aggressive treatment that may slow or prevent progression of the disease.

Three types of standard treatment are used:

MDS Symptoms and Diagnosis

Myelodysplastic syndromes often do not cause early symptoms and are sometimes found during a routine blood test. Other conditions may cause the same symptoms. A doctor should be consulted if any of the following problems occur:
  • Shortness of breath.
  • Weakness or feeling tired.
  • Easy bruising or bleeding.
  • Petechiae (flat, pinpoint spots under the skin caused by bleeding).
  • Fever or frequent infections.
  • Bone pain.

Diagnosis/Screening for Myelodysplastic syndromes

  • Physical exam and history:

Pages